← Back
Data updated: Mar 29, 2026
STEMLINE THERAPEUTICS INC
OncologyImmunologyDermatology
Biotech
STEMLINE THERAPEUTICS INC is a biotechnology company focused on Oncology, Immunology, Dermatology.
2018
Since
1
Drugs
-
Trials
0
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 51%
1 drugs Phase 3: 2 Phase 2: 2 Phase 1: 12
Immunology 44%
0 drugs Phase 3: 5 Phase 2: 3
Dermatology 3%
0 drugs Phase 2: 1
Gastroenterology 2%
0 drugs Phase 1: 1
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Pfizer big-pharma
Oncology, Dermatology, Immunology, Gastroenterology
Eli Lilly big-pharma
Oncology, Immunology, Dermatology
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Gastroenterology
BAUSCH specialty
Dermatology, Immunology, Gastroenterology
COSETTE other
Dermatology, Immunology, Oncology
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2018-12-21
- Latest
- 2023-07-26
- Applications
- 1